Una historia resumida. Impacto de los avances en cardiopatía isquémica

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Revista Española de Cardiología Suplementos

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/S1131-3587(19)30009-3
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• 2018 ESC/EACTS Guidelines on myocardial revascularization.

  2019cited by this paper
• International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design

  2018cited by this paper
• Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease

  2017cited by this paper
• 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

  2016cited by this paper
• 2016 European Guidelines on cardiovascular disease prevention in clinical practice.

  2016cited by this paper
• Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.

  2016cited by this paper
• Comparative Effectiveness and Safety of New-Generation Versus Early-Generation Drug-Eluting Stents According to Complexity of Coronary Artery Disease: A Patient-Level Pooled Analysis of 6,081 Patients.

  2015cited by this paper
• Long-term use of ticagrelor in patients with prior myocardial infarction.

  2015cited by this paper
• Ezetimibe added to statin therapy after acute coronary syndromes

  2015cited by this paper
• Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

  2015cited by this paper
• Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.

  2015cited by this paper
• Angiotensin-neprilysin inhibition versus enalapril in heart failure.

  2014cited by this paper
• ESC / EACTS Guidelines on myocardial revascularization

  2014cited by this paper
• Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia: a collaborative meta-analysis of contemporary randomized clinical trials.

  2014cited by this paper
• An analysis of TRITON-TIMI 38, based on the 12 month recommended length of therapy in the European label for prasugrel

  2014cited by this paper
• [2014 ESC/EACTS Guidelines on myocardial revascularization].

  2014cited by this paper
• Meta-analysis of time-related benefits of statin therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention.

  2014cited by this paper
• Clinical outcomes with β-blockers for myocardial infarction: a meta-analysis of randomized trials.

  2014cited by this paper
• Novel oral anticoagulants in acute coronary syndrome.

  2013cited by this paper
• 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.

  2013cited by this paper
• ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

  2012cited by this paper
• Impact on delay times and characteristics of patients undergoing primary percutaneous coronary intervention in the southern metropolitan area of Barcelona after implementation of the infarction code program.

  2012cited by this paper
• Hypothermia in Comatose Survivors From Out-of-Hospital Cardiac Arrest: Pilot Trial Comparing 2 Levels of Target Temperature

  2012cited by this paper
• Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient Outcomes (PLATO) trial

  2011cited by this paper
• 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC).

  2011cited by this paper
• Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.

  2010cited by this paper
• Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study.

  2010cited by this paper
• Cardiovascular Disease Prevention in Clinical Practice

  2010cited by this paper
• Low-dose vs standard-dose unfractionated heparin for percutaneous coronary intervention in acute coronary syndromes treated with fondaparinux: the FUTURA/OASIS-8 randomized trial.

  2010cited by this paper
• Ticagrelor versus clopidogrel in patients with acute coronary syndromes.

  2009cited by this paper
• Cardiac-resynchronization therapy for the prevention of heart-failure events.

  2009cited by this paper
• Guidelines for management of arterial hypertension

  2007cited by this paper
• Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

  2007cited by this paper
• Prasugrel versus clopidogrel in patients with acute coronary syndromes.

  2007cited by this paper
• Use of a continuous-flow device in patients awaiting heart transplantation.

  2007cited by this paper
• 2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

  2007cited by this paper
• Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial.

  2006cited by this paper
• Guidelines on the management of stable angina pectoris.

  2006cited by this paper
• Comparison of fondaparinux and enoxaparin in acute coronary syndromes.

  2006cited by this paper
• Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.

  2005cited by this paper
• Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial.

  2005cited by this paper
• Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial.

  2005cited by this paper
• Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study.

  2005cited by this paper
• Expert consensus document on beta-adrenergic receptor blockers.

  2004cited by this paper
• Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-inhibitors of the European Society of Cardiology.

  2004cited by this paper
• HLA-MATCHING AND PRETRANSPLANT BLOOD TRANSFUSIONS IN CADAVERIC RENAL TRANSPLANTATION—A CHANGING PICTURE WITH CYCLOSPORIN

  2003cited by this paper
• Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

  2003cited by this paper
• PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION

  2002cited by this paper
• For personal use. Only reproduce with permission from The Lancet Publishing Group. Late cardiopulmonary complication of ventriculo-atrial shunt

  2001cited by this paper
• Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.

  2001cited by this paper
• The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

  2000cited by this paper
• The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

  1999cited by this paper
• Primary angioplasty versus systemic thrombolysis in anterior myocardial infarction.

  1999cited by this paper
• Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review.

  1998cited by this paper
• Secular trends in long-term sustained hypertension, long-term treatment, and cardiovascular mortality. The Framingham Heart Study 1950 to 1990.

  1996cited by this paper
• ISIS-4 - A randomised factorial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58.050 patient with suspected acute myocardial-infarction.

  1995cited by this paper
• Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients

  1994cited by this paper
• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

  1994cited by this paper
• GISSI-3: effects of lisiriopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction

  1994cited by this paper
• Indications for fibrinolytic therapy in suspected acute myocardial infarction : collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

  1994cited by this paper
• A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial Infarction

  1993cited by this paper
• Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

  1992cited by this paper
• Randomised controlled trial of subcutaneous calcium-heparin in acute myocardial infarction

  1989cited by this paper
• Antithrombotic agents in coronary artery disease.

  1989cited by this paper
• Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

  1988cited by this paper
• RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2

  1988cited by this paper
• Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1

  1987cited by this paper
• Six-year follow-up of the Norwegian multicenter study on timolol after myocardial infarction.

  1986cited by this paper
• Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial.

  1985cited by this paper
• Textbook of Coronary Care

  1972cited by this paper
• The Place of the Coronary Care Unit

  1968cited by this paper
• Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients.

  1967cited by this paper

• COMPLETE revascularization after STEMI? Sure, go ahead

  2020cites this paper